Scientists engineer new CRISPR platform for DNA targeting
CRISPR team harnesses new Cas12b enzyme for use in eukaryotic cells, adding to the CRISPR toolbox.
New CRISPR tool opens up more of the genome for editing
Enzyme can target almost half of the genome’s “ZIP codes” and could enable editing of many more disease-specific mutations.
Feng Zhang wins 2018 Keio Medical Science Prize
McGovern Institute scientist is recognized with award for outstanding and creative achievements made in the life and medical sciences.
Scientists sharpen the edges of cancer chemotherapy
Whitehead team deploys CRISPR tools to better understand and uncover ways of improving methotrexate, a popular chemotherapy drug.
Scene at MIT: PhD baby and her amazing mama
A new daughter helped Alejandra Falla PhD ’18 gain perspective on life — and her tiny MIT regalia stole the show at Commencement.
Neuroscientists discover roles of gene linked to Alzheimer’s
Study reveals why people with the APOE4 gene have higher risk of the disease.
Researchers advance CRISPR-based tool for diagnosing disease
With SHERLOCK, a strip of paper can now indicate presence of pathogens, tumor DNA, or any genetic signature of interest.
Study: Fragile X syndrome neurons can be restored
Whitehead Institute researchers are using a modified CRISPR/Cas9-guided activation strategy to investigate the most frequent cause of intellectual disability in males.
Reading and writing DNA
Department of Biology kicks off IAP seminar series with a lecture by synthetic-biology visionary George Church.
CRISPR-carrying nanoparticles edit the genome
New delivery system developed by MIT team deletes disease-causing genes and reduces cholesterol.
Researchers engineer CRISPR to edit single RNA letters in human cells
“REPAIR” system edits RNA, rather than DNA; has potential to treat diseases without permanently affecting the genome.
New technique scours the genome for genes that combat disease
Biological engineers identify genes that protect against protein linked to Parkinson’s disease.
Gene-editing technology developer Feng Zhang awarded $500,000 Lemelson-MIT Prize
MIT associate professor and member of the Broad Institute and McGovern Institute recognized for commitment to invention, collaboration, and mentorship.
Feng Zhang to share Albany Medical Prize
Five recipients honored for their fundamental and complementary accomplishments related to CRISPR-Cas9.
Deploying therapeutic payloads to cells
Mark Bathe develops molecular packages for targeted delivery of drugs, vaccines, and gene-editing tools.